Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid 0.54% Gel vs Calgel for Teething in Infants
NCT02931357Phase 3Completed
- Sponsor
- Ricerfarma
- Start
- Sep 2013
- Primary completion
- Sep 2013
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Ricerfarma. Primary endpoint: Teething pain at Day 7. Started Sep 2013; status: completed.
Beyond the preview
Go deeper on NCT02931357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02931357.